| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 3,801,000 | $91,033,950 | $23.95 | 11 Aug 2025 | By Frazier Lifesciences Sponsor LLC |
| NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 3,026,604 | $72,574,029 | $23.98 | 11 Aug 2025 | By Frazier Life Sciences X, L.P. |
| Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 5,827,415 | $19,288,743 | $3.31 | 03 Jun 2025 | By Frazier Life Sciences IX, L.P. |
| Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 59,403 | $196,623 | $3.31 | 03 Jun 2025 | By Frazier Life Sciences X, L.P. |
| Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 42,596 | $140,992 | $3.31 | 03 Jun 2025 | Direct |
| ANAPTYSBIO, INC | Director, 10%+ Owner | Restricted Stock Unit | 3,900 | $85,059 | $21.81 | 06 Jan 2023 | Direct |
| Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 3,912 | $12,948 | $3.31 | 03 Jun 2025 | By Topper Group III LLC |
| Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 1 | $3 | $3.31 | 03 Jun 2025 | By FHMLS IX, L.L.C. |
| ALPINE IMMUNE SCIENCES, INC. | Director | Common Stock | 0 | $0 | $6.33 | 18 May 2024 | By Frazier Life Sciences VIII, L.P. |
| Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 17,500 | 03 Jun 2025 | Direct | ||
| ANAPTYSBIO, INC | Director, 10%+ Owner | Stock Option (right to buy) | 10,600 | 06 Jan 2023 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | 20 May 2024 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director | Warrant (Right to Buy) | 0 | 25 Apr 2024 | By: Frazier Life Sciences VIII, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | 15 Sep 2025 | 1 | +$15,639 | 4 | Director | 17 Sep 2025, 17:22 |
| NAMS | NewAmsterdam Pharma Co N.V. | 08 Sep 2025 | 1 | +$31,487 | 4 | Director | 10 Sep 2025, 17:19 |
| NAMS | NewAmsterdam Pharma Co N.V. | 11 Aug 2025 | 1 | +$11,294 | 4 | Director | 13 Aug 2025, 16:49 |
| NAMS | NewAmsterdam Pharma Co N.V. | 24 Jun 2025 | 2 | +$69,466 | 4 | Director | 26 Jun 2025, 19:41 |
| NAMS | NewAmsterdam Pharma Co N.V. | 16 Jun 2025 | 1 | +$167,381 | 4 | Director | 18 Jun 2025, 16:42 |
| PHAT | Phathom Pharmaceuticals, Inc. | 03 Jun 2025 | 2 | $0 | 4 | Director, 10%+ Owner | 05 Jun 2025, 16:56 |
| PHAT | Phathom Pharmaceuticals, Inc. | 21 May 2025 | 1 | +$14,609 | 4 | Director | 23 May 2025, 16:06 |
| PHAT | Phathom Pharmaceuticals, Inc. | 13 May 2025 | 2 | +$24,462 | 4 | Director | 15 May 2025, 16:17 |
| PHAT | Phathom Pharmaceuticals, Inc. | 09 May 2025 | 3 | +$152,917 | 4 | Director | 13 May 2025, 16:13 |
| NAMS | NewAmsterdam Pharma Co N.V. | 26 Mar 2025 | 1 | +$25,521 | 4 | Director | 28 Mar 2025, 17:36 |
| NAMS | NewAmsterdam Pharma Co N.V. | 04 Mar 2025 | 1 | +$84,203 | 4 | Director | 06 Mar 2025, 17:32 |
| PHAT | Phathom Pharmaceuticals, Inc. | 23 May 2024 | 2 | $0 | 4 | Director, 10%+ Owner | 24 May 2024, 19:47 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 18 May 2024 | 8 | $0 | 4 | Director | 20 May 2024, 20:10 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 25 Apr 2024 | 3 | -$26.83 | 4 | Director | 29 Apr 2024, 16:32 |
| NAMS | NewAmsterdam Pharma Co N.V. | 26 Mar 2024 | 1 | +$181,224 | 4 | Director | 28 Mar 2024, 16:30 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 02 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 19:03 |
| NAMS | NewAmsterdam Pharma Co N.V. | 29 Dec 2023 | 0 | $0 | 3 | Director | 29 Dec 2023, 16:30 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 11 Dec 2023 | 2 | +$1,850,498 | 4 | Director | 13 Dec 2023, 17:30 |
| PHAT | Phathom Pharmaceuticals, Inc. | 25 May 2023 | 2 | $0 | 4 | Director, 10%+ Owner | 30 May 2023, 19:03 |
| ANAB | ANAPTYSBIO, INC | 06 Jan 2023 | 2 | $0 | 4 | Director, 10%+ Owner | 10 Jan 2023, 18:13 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 18:00 |
| PHAT | Phathom Pharmaceuticals, Inc. | 22 Sep 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 26 Sep 2022, 16:09 |
| ANAB | ANAPTYSBIO, INC | 10 Feb 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 14 Feb 2022, 15:51 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 03 Jan 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 04 Jan 2022, 16:28 |